Cover Image
市場調查報告書

頭頸部復發性表皮鱗狀上皮細胞癌:全球臨床實驗檢討

Recurrent Head And Neck Cancer Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 300504
出版日期 內容資訊 英文 176 Pages
訂單完成後即時交付
價格
Back to Top
頭頸部復發性表皮鱗狀上皮細胞癌:全球臨床實驗檢討 Recurrent Head And Neck Cancer Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014
出版日期: 2014年04月24日 內容資訊: 英文 176 Pages
簡介

本報告提供頭頸部復發性表皮鱗狀上皮細胞癌相關臨床研究最新趨勢相關分析,疾病·治療方法概要,及主要已開發國家·新興國家的臨床實驗狀況,各地區、Phase別的進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊彙整,為您概述為以下內容。

目錄

簡介

  • 頭頸部復發性表皮鱗狀上皮細胞癌
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區前五名國家的臨床實驗數量
    • 歐洲前五名國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量
    • 中南美前五名國家的臨床實驗數量

G7各國臨床實驗數量:佔腫瘤整體比率

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:佔腫瘤整體比率

E7各國臨床實驗數量:Phase別

E7各國臨床實驗數量:各進展狀況

Phase別臨床實驗數量

  • 進行中的臨床實驗:Phase別

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

  • 參加頭頸部復發性表皮鱗狀上皮細胞癌的治療藥臨床實驗的前幾名企業

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • Sanofi
    • E. Merck KG
    • Novartis AG
    • Eli Lilly and Company
    • AstraZeneca PLC
    • F. Hoffmann-La Roche Ltd.
    • Pfizer Inc.
    • Amgen Inc.
    • GlaxoSmithKline plc
    • C. H. Boehringer Sohn AG & Co. KG
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • The University of Texas M. D. Anderson Cancer Center
    • European Organization for Research and Treatment of Cancer
    • The University of Chicago
    • Memorial Sloan Kettering Cancer Center
    • University of Pittsburgh
    • Southwest Oncology Group
    • Roswell Park Cancer Institute
    • Sidney Kimmel Comprehensive Cancer Center
    • Eastern Cooperative Oncology Group

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2098CTIDB

GlobalData's clinical trial report, "Recurrent Head And Neck Cancer Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Recurrent Head And Neck Cancer Squamous Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Recurrent Head And Neck Cancer Squamous Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Recurrent Head And Neck Cancer Squamous Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Recurrent Head And Neck Cancer Squamous Cell Carcinoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Recurrent Head And Neck Cancer Squamous Cell Carcinoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Recurrent Head And Neck Cancer Squamous Cell Carcinoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Recurrent Head And Neck Cancer Squamous Cell Carcinoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • E. Merck KG
      • Clinical Trial Overview of E. Merck KG
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • The University of Chicago
      • Clinical Trial Overview of The University of Chicago
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • Southwest Oncology Group
      • Clinical Trial Overview of Southwest Oncology Group
      • Roswell Park Cancer Institute
      • Clinical Trial Overview of Roswell Park Cancer Institute
      • Sidney Kimmel Comprehensive Cancer Center
      • Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
      • Eastern Cooperative Oncology Group
      • Clinical Trial Overview of Eastern Cooperative Oncology Group
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Region, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Recurrent Head And Neck Cancer Squamous Cell Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Recurrent Head And Neck Cancer Squamous Cell Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2014*

List of Figures

  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Recurrent Head And Neck Cancer Squamous Cell Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Recurrent Head And Neck Cancer Squamous Cell Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Recurrent Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top